4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-16-006268
Director bought 808 shares at $6.51 ($5,260)
- Director acquired 70 shares (code L)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2016-10-25 | Other acquisition | +6 | $6.51 | $39 | 66,791 | I |
| Eberwein Jeffrey E. Director | 2016-10-27 | Other acquisition | +1 | $6.51 | $7 | 66,792 | I |
| Eberwein Jeffrey E. Director | 2016-11-15 | Other acquisition | +3 | $6.51 | $20 | 66,795 | I |
| Eberwein Jeffrey E. Director | 2016-11-22 | Other acquisition | +23 | $6.51 | $150 | 66,818 | I |
| Eberwein Jeffrey E. Director | 2016-11-25 | Other acquisition | +2 | $6.51 | $13 | 66,820 | I |
| Eberwein Jeffrey E. Director | 2016-11-29 | Other acquisition | +35 | $6.51 | $228 | 66,855 | I |
| Eberwein Jeffrey E. Director | 2016-11-30 | Purchase | +807 | $6.51 | $5,254 | 67,662 | I |
| Eberwein Jeffrey E. Director | 2016-12-02 | Purchase | +1 | $6.51 | $7 | 67,663 | I |
| Open-market purchases · 808 sh · avg $6.51 · $5,260 | |||||||
Loading xslF345X03/form410211002_12022016.xml…